These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2584354)

  • 21. Combined effects of RU486 and tamoxifen on the growth and cell cycle phases of the MCF-7 cell line.
    Thomas M; Monet JD
    J Clin Endocrinol Metab; 1992 Sep; 75(3):865-70. PubMed ID: 1517379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer?
    Horwitz KB
    Endocr Rev; 1992 May; 13(2):146-63. PubMed ID: 1618161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progesterone-induced immunosuppression is not mediated through the progesterone receptor.
    Schust DJ; Anderson DJ; Hill JA
    Hum Reprod; 1996 May; 11(5):980-5. PubMed ID: 8671374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception.
    Glasier A; Thong KJ; Dewar M; Mackie M; Baird DT
    N Engl J Med; 1992 Oct; 327(15):1041-4. PubMed ID: 1522839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of RU 38,486 on progesterone and oestrogen receptor concentrations in the decidua and placenta in early pregnancy.
    Hill NC; Rivera J; Lopez Bernal A; MacKenzie IZ
    Hum Reprod; 1990 May; 5(4):464-7. PubMed ID: 2362009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct suppression of cultured spleen cell responses by chlordane and the basis for differential effects on in vivo and in vitro immunocompetence.
    Johnson KW; Kaminski NE; Munson AE
    J Toxicol Environ Health; 1987; 22(4):497-515. PubMed ID: 3694709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transient inhibition of RU 486 antiglucocorticoid action by dexamethasone.
    Raux-Demay MC; Pierret T; Bouvier d'Yvoire M; Bertagna X; Girard F
    J Clin Endocrinol Metab; 1990 Jan; 70(1):230-3. PubMed ID: 2152931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early changes of affinity and binding sites of progesterone and oestrogen receptors in decidua exposed to RU 486.
    Shi WL; Wang JD; Xu LK; Fu Y; Zhu PD; Qiao GM; Wang YQ
    Hum Reprod; 1992 Aug; 7(7):934-9. PubMed ID: 1430132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucocorticoid suppression of human lymphocyte DNA synthesis: influence of phytohemagglutinin concentration.
    Segel GB; Lukacher A; Gordon BR; Lichtman MA
    J Lab Clin Med; 1980 Apr; 95(4):624-32. PubMed ID: 7359015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of RU 486 on progesterone receptor in villous and extravillous trophoblast.
    Shi WL; Wang JD; Fu Y; Xu LK; Zhu PD
    Hum Reprod; 1993 Jun; 8(6):953-8. PubMed ID: 7688381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced effects of prostaglandin E1 and dibutyryl cyclic AMP upon human lymphocytes in the presence of cortisol.
    Mendelsohn J; Multer MM; Boone RF
    J Clin Invest; 1973 Sep; 52(9):2129-37. PubMed ID: 4353772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
    Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
    J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The endocrine effects of long-term treatment with mifepristone (RU 486).
    Lamberts SW; Koper JW; de Jong FH
    J Clin Endocrinol Metab; 1991 Jul; 73(1):187-91. PubMed ID: 1646217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell stromelysin-1 and prolactin expression.
    Schatz F; Papp C; Aigner S; Krikun G; Hausknecht V; Lockwood CJ
    J Clin Endocrinol Metab; 1997 Jan; 82(1):188-93. PubMed ID: 8989257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of proliferation and differentiation by RU 486 in human endometrial stromal and epithelial cells in vitro.
    Prange-Kiel J; Rune GM; Wallwiener D; Kiesel L
    Exp Clin Endocrinol Diabetes; 2000; 108(4):275-81. PubMed ID: 10961358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Requirement for prostaglandin F2 alpha in 17 beta-estradiol stimulation of DNA synthesis in rabbit endometrial cultures.
    Orlicky DJ; Lieberman R; Williams C; Gerschenson LE
    J Cell Physiol; 1987 Feb; 130(2):292-300. PubMed ID: 3469206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Termination of early pregnancy by the progesterone antagonist RU 486 (Mifepristone).
    Couzinet B; Le Strat N; Ulmann A; Baulieu EE; Schaison G
    N Engl J Med; 1986 Dec; 315(25):1565-70. PubMed ID: 3785321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro study of the modification by bleomycin of thymidine phosphorylation activity in lectin-stimulated normal human lymphocytes.
    Sharif A; Goussault Y
    Cancer Biochem Biophys; 1988 Jul; 10(1):17-24. PubMed ID: 2465077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of mixed lymphocyte reaction by progesterone and estradiol-17beta.
    Kobayashi H; Mori T; Suzuki A; Nishimura T; Nishimoto H; Harada M
    Am J Obstet Gynecol; 1979 Jun; 134(3):255-9. PubMed ID: 156501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.